Cargando…
Feasibility of a multiparametric MRI protocol for imaging biomarkers associated with neoadjuvant radiotherapy for soft tissue sarcoma
OBJECTIVE: Soft tissue sarcoma (STS) is a rare malignancy with a 5 year overall survival rate of 55%. Neoadjuvant radiotherapy is commonly used in preparation for surgery, but methods to assess early response are lacking despite pathological response at surgery being predictive of overall survival,...
Autores principales: | Kershaw, Lucy, Forker, Laura, Roberts, Darren, Sanderson, Benjamin, Shenjere, Patrick, Wylie, James, Coyle, Catherine, Kochhar, Rohit, Manoharan, Prakash, Choudhury, Ananaya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The British Institute of Radiology.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9185851/ https://www.ncbi.nlm.nih.gov/pubmed/35707756 http://dx.doi.org/10.1259/bjro.20200061 |
Ejemplares similares
-
Does magnetic resonance imaging improve soft tissue sarcoma contouring for radiotherapy?
por: Vickers, Alexander John, et al.
Publicado: (2019) -
The hypoxia marker CAIX is prognostic in the UK phase III VorteX-Biobank cohort: an important resource for translational research in soft tissue sarcoma
por: Forker, Laura, et al.
Publicado: (2018) -
Technical development and validation of a clinically applicable microenvironment classifier as a biomarker of tumour hypoxia for soft tissue sarcoma
por: Forker, Laura J., et al.
Publicado: (2023) -
Non-invasive Monitoring of Soft-tissue Sarcoma Response to Neoadjuvant Radiotherapy by Quantification of Circulating Tumor DNA (ctDNA) and Multiparametric MRI (mpMRI)
por: Runkel, Alexander, et al.
Publicado: (2023) -
Radiographic and Histologic Response to Neoadjuvant Radiotherapy in Patients With Soft Tissue Sarcoma
por: Canter, Robert J., et al.
Publicado: (2010)